A clinical study to evaluate Ayurvedic treatment in patients with diabetic neuropathy

A single arm clinical study to evaluate the efficacy of Dashamooladi ghana vati Pramehahara kashaya & Amritothara taila in the management of diabetic neuropathy. - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/114076

Enrollment

Registered

2026-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender having age between 30 to 70 years 2. Confirmed diagnosed patients of Diabetes Mellitus who are on oral hypoglycemic drugs with signs and symptoms of Peripheral Neuropathy 3. Patients with Fasting Plasma Glucose value between 110 to 220 mg per dl 4. Patients with HbA1c level less than 8 percent

Exclusion criteria

Exclusion criteria: 1 Patients having Ischemic heart disease, Hereditary sensory and motor neuropathy, Bleedind disorder, TB, Patients with pacemaker and Inflammatory neuropathies 2 Patients with uncontrolled hypertension, uncontrolled diabetes and other endocrine disoreders 3 Pregnant women and lactating mother 4 Patients having corticosteroids, anti psychotic, anti anxiety drugs

Design outcomes

Primary

Measure	Time frame
1 Changes in Modified Toronto Clinical Neuropathy ScoreTimepoint: 8 weeks	—

Secondary

Measure	Time frame
1 Changes in Nerve conduction velocity 2 Changes in biochemical parametersTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactProf HML Meena

National Institute of Ayurveda Deemed to be University Jaipur

hari_mohan68@yahoo.co.in9461297017

Outcome results